See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Roche Holding AG (RHHBY) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Roche Holding AG (RHHBY) - free report >>
Image: Bigstock
Can the Strong Economy Save the Stock Market?
The U.S. economy remains on a solid footing. We’re going to talk about that now with our Chief Equity Strategist and Economist, John Blank.
1. Is our economy in the late stages of expansion as some are saying?
2. What should we be seeing in order for the expansion to continue?
3. What’s the impact from the trade situation and other geopolitical tensions presently?
4. Will tighter global trade conditions slow the global economy?
5. Is the Fed on the right track with rate increases given the solid footing we’re on?
6. How long into next year do you think our economy remains on this solid footing?
7. You’re eyeing up three major large cap pharma stocks…Roche Holding AG (RHHBY - Free Report) , Gilead Sciences (GILD - Free Report) and Bristol Myers Squibb (BMY - Free Report) .
That’s the latest with our Chief Equity Strategist and Economist, John Blank. With John I’m Terry Ruffolo.